JP3141601B2 - CATHETER FOR TREATMENT OF LOCAL ANEMIA AND TREATMENT DEVICE USING THE SAME - Google Patents
CATHETER FOR TREATMENT OF LOCAL ANEMIA AND TREATMENT DEVICE USING THE SAMEInfo
- Publication number
- JP3141601B2 JP3141601B2 JP05027321A JP2732193A JP3141601B2 JP 3141601 B2 JP3141601 B2 JP 3141601B2 JP 05027321 A JP05027321 A JP 05027321A JP 2732193 A JP2732193 A JP 2732193A JP 3141601 B2 JP3141601 B2 JP 3141601B2
- Authority
- JP
- Japan
- Prior art keywords
- liquid
- lumen
- catheter
- tube
- oxygen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000007502 anemia Diseases 0.000 title claims description 29
- 239000007788 liquid Substances 0.000 claims description 100
- 229910052760 oxygen Inorganic materials 0.000 claims description 70
- 239000001301 oxygen Substances 0.000 claims description 70
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 69
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 69
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 35
- 238000011084 recovery Methods 0.000 claims description 35
- 239000001569 carbon dioxide Substances 0.000 claims description 33
- 238000005259 measurement Methods 0.000 claims description 14
- 229920003002 synthetic resin Polymers 0.000 claims description 9
- 239000000057 synthetic resin Substances 0.000 claims description 9
- 239000007789 gas Substances 0.000 claims description 6
- -1 polypropylene Polymers 0.000 claims description 5
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 4
- 229910001882 dioxygen Inorganic materials 0.000 claims description 4
- 229920002379 silicone rubber Polymers 0.000 claims description 4
- 239000004945 silicone rubber Substances 0.000 claims description 4
- 238000011144 upstream manufacturing Methods 0.000 claims description 4
- 239000004743 Polypropylene Substances 0.000 claims description 2
- MSVGHYYKWDQHFV-BQYQJAHWSA-N ditert-butyl (e)-but-2-enedioate Chemical compound CC(C)(C)OC(=O)\C=C\C(=O)OC(C)(C)C MSVGHYYKWDQHFV-BQYQJAHWSA-N 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 2
- 229920002050 silicone resin Polymers 0.000 claims description 2
- 238000006213 oxygenation reaction Methods 0.000 claims 1
- 239000002473 artificial blood Substances 0.000 description 19
- 210000004400 mucous membrane Anatomy 0.000 description 13
- 239000000243 solution Substances 0.000 description 12
- 210000001035 gastrointestinal tract Anatomy 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 8
- 210000000936 intestine Anatomy 0.000 description 7
- 230000000302 ischemic effect Effects 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 210000000813 small intestine Anatomy 0.000 description 5
- 230000004087 circulation Effects 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 210000000056 organ Anatomy 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 210000004347 intestinal mucosa Anatomy 0.000 description 3
- 210000004379 membrane Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- TXEYQDLBPFQVAA-UHFFFAOYSA-N tetrafluoromethane Chemical compound FC(F)(F)F TXEYQDLBPFQVAA-UHFFFAOYSA-N 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 208000010444 Acidosis Diseases 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 208000034486 Multi-organ failure Diseases 0.000 description 2
- 208000010718 Multiple Organ Failure Diseases 0.000 description 2
- 230000007950 acidosis Effects 0.000 description 2
- 208000026545 acidosis disease Diseases 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 238000002615 hemofiltration Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 2
- 235000016236 parenteral nutrition Nutrition 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 208000028399 Critical Illness Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 208000002223 abdominal aortic aneurysm Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 208000007474 aortic aneurysm Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002350 laparotomy Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000001363 mesenteric artery superior Anatomy 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- External Artificial Organs (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は虚血状態(生体組織の局
所的な貧血状態を言い、ここでは特に虚血に因って生ず
る酸素不足状態を言う)にある管状組織、特に胃腸内に
留置して、それらの組織粘膜に対して酸素を付与し治療
するための局所性貧血治療用カテーテルおよびこれを用
いた治療装置に関する。BACKGROUND OF THE INVENTION The present invention relates to tubular tissue, particularly gastrointestinal tract, in an ischemic condition (referring to a local anemia condition in a living tissue, and particularly to a lack of oxygen caused by ischemia). The present invention relates to a local anemia treatment catheter for indwelling and applying oxygen to those tissue mucous membranes for treatment, and a treatment apparatus using the same.
【0002】[0002]
【従来の技術】救急患者や集中治療室(ICU)の患者
などの重症患者の場合、腹部大動脈瘤等の大手術後、動
脈内バルーンポンピング(IABP)等における補助循
環装置離脱後、あるいは種々の感染により体の各組織へ
の酸素供給能が低下した場合、組織が酸素供給依存型の
状態に陥る。この様な場合に、腸管の血流障害等が原因
となり、腸粘膜が虚血状態に陥りやすいことが知られて
いる。この様な状態になると組織がアシドーシス状態に
なり、腸液等の体液のpHが低下し臓器の機能が低下す
る。すると連鎖反応的に門脈等の血管で繋がれている周
りの心臓、腎臓、肝臓といった重要臓器機能にも同じよ
うな影響が出始め、最後には多臓器不全(MOF)に陥
り死亡するという結果になる可能性が高い。この様な問
題に対処するには、術中、術後の患者や一般重症患者の
管理方法の改善が必要なことから、従来、虚血状態など
の組織酸素代謝障害の改善方法として、抗生物質(バ
ンコマイシンなど)の静脈内投与などの薬物投与、慢
性的血液濾過(CHF)、慢性的血液濾過透析(CHD
F)などの体外循環、中心静脈栄養(IVH)などの
非経口的栄養(TPN)療法などが提案されており、ま
た、直接腸内に酸素を溶解させた人工血液を入れて腸
管粘膜に酸素を付与する方法も提案されている。2. Description of the Related Art In the case of critically ill patients such as emergency patients and patients in an intensive care unit (ICU), after major surgery such as abdominal aortic aneurysm, after withdrawal from an auxiliary circulation device such as intra-arterial balloon pumping (IABP), or various other cases. When the infection decreases the ability of the body to supply oxygen to tissues, the tissues fall into an oxygen supply-dependent state. In such a case, it is known that intestinal mucosa is likely to be in an ischemic state due to impaired blood flow in the intestinal tract and the like. In such a state, the tissue becomes an acidosis state, the pH of a body fluid such as intestinal fluid decreases, and the function of the organ decreases. Then, similar effects begin to occur on vital organ functions such as the heart, kidneys, and liver, which are connected in a chain reaction by blood vessels such as the portal vein, and eventually die of multiple organ failure (MOF) It is likely to be the result. To cope with such problems, it is necessary to improve the management method of patients during and after surgery and patients with general severe condition. Conventionally, antibiotics ( Drug administration, such as intravenous administration of chronic hemofiltration (CHF), chronic hemofiltration dialysis (CHD)
F) and the like, and parenteral nutrition (TPN) therapy such as central parenteral nutrition (IVH), etc., and artificial blood in which oxygen is dissolved directly in the intestine to put oxygen into the intestinal mucosa. Has also been proposed.
【0003】しかしながら、については、薬物の副作
用による影響が問題であり、については、補助循環装
置を離脱する時期の予測が困難であるという欠点を有し
ており、については、現在市販されているカテーテル
では未だ有効な治療効果が得られておらず、について
も、腸内が人工血液によって膨満状態になってしまい中
を循環させ難い、腸内の人工血液が汚物で汚され酸素付
与機能が低下する、目的部位以外にまで人工血液が流れ
込み酸素付与効率が悪い、などの欠点を有するものであ
る。尚、虚血状態の検査およびその前兆を知る方法とし
ては、内視鏡やドップラー血流計等を用いる方法や、蛍
光染色法、カテーテルを用いて胃、腸の臓器内の炭酸ガ
ス分圧と、動脈血の炭酸ガスイオン濃度を測定し、これ
らを用いて臓器壁のpHを計算して虚血状態の尺度とす
る方法(アメリカ特許第 4,643,192号)などがある。[0003] However, there is a problem that the effect of the side effect of the drug is a problem, and it is difficult to predict when to leave the auxiliary circulatory device. The catheter has not yet obtained an effective therapeutic effect, and the intestine is inflated by artificial blood, making it difficult to circulate through the blood.The artificial blood in the intestine is contaminated with dirt, and the oxygen supply function is reduced. And artificial blood flows into areas other than the target site, resulting in poor oxygen application efficiency. In addition, as a method for examining the ischemic state and knowing the precursor thereof, a method using an endoscope or a Doppler blood flow meter, a fluorescent staining method, a carbon dioxide partial pressure in organs of the stomach and intestine using a catheter and the like are used. And a method of measuring the carbon dioxide ion concentration of arterial blood and calculating the pH of the organ wall using the measured values to determine the ischemic state (US Pat. No. 4,643,192).
【0004】[0004]
【発明が解決しようとする課題】本発明は上記のような
事情に鑑みてなされたもので、胃や腸の粘膜組織の虚血
状態(酸素不足状態)を改善するために、胃や腸内を汚
すことなく効率的に胃や腸の粘膜組織に酸素を付与する
ことのできる局所性貧血治療用カテーテルを提供するこ
とを目的とする。さらに本発明は、虚血状態の診断部分
と治療部分を一体化することによって、手技の簡素化を
図り、副作用を最小限に抑えることによって患者の負担
を軽減することのできる局所性貧血治療用カテーテルを
提供することを目的とする。SUMMARY OF THE INVENTION The present invention has been made in view of the above-mentioned circumstances, and is intended to improve the ischemic state (oxygen-deficient state) of mucosal tissues of the stomach and intestines. An object of the present invention is to provide a catheter for treating local anemia, which can efficiently provide oxygen to the mucosal tissues of the stomach and intestine without soiling. Furthermore, the present invention provides a method for treating local anemia that can simplify the procedure by integrating the diagnostic part and the therapeutic part of the ischemic condition, and reduce the burden on the patient by minimizing the side effects. It is intended to provide a catheter.
【0005】[0005]
【課題を解決するための手段】本発明は、上記の課題を
解決するために、第1の発明として、その長手方向に液
体供給用ルーメンおよび液体回収用ルーメンが形成され
てなるメインチューブと、該メインチューブの先端部お
よび/または中間部の外壁に設けられ、前記液体供給用
ルーメンおよび液体回収用ルーメンとそれぞれ連通する
1つまたは複数の酸素供給バルーンと、前記メインチュ
ーブの基端部で前記液体供給用ルーメンおよび液体回収
用ルーメンにそれぞれ接続された液体供給チューブおよ
び液体回収チューブとからなり、酸素供給バルーンをガ
ス透過性かつ液体不透過性の合成樹脂で形成するととも
に、液体を流したときの液体回収側の流路の抵抗を液体
供給側の流路の抵抗よりも大きくし、前記メインチュー
ブの外壁に酸素供給用バルーンに近接して、さらにガス
透過性かつ液体不透過性の合成樹脂で制せられた1つま
たは複数の炭酸ガス濃度測定バルーンを設け、該炭酸ガ
ス濃度測定バルーンをそれぞれメインチューブに別途形
成した炭酸ガス濃度測定用ルーメンを介して炭酸ガス濃
度測定チューブと連通接続したことを特徴とする局所性
貧血治療用カテーテルを採用している。また、第2の発
明として、請求項1に記載の局所性貧血治療用カテーテ
ルと、該局所性貧血治療用カテーテルの液体供給チュー
ブの上流に接続された液体供給ポンプ、および該液体供
給ポンプの上流と局所性貧血治療用カテーテルの液体回
収チューブの下流に接続された液体収容容器からなり、
該液体収容容器が酸素ガス供給手段との接続手段を有し
ている治療装置を採用している。According to a first aspect of the present invention, there is provided a main tube having a liquid supply lumen and a liquid recovery lumen formed in a longitudinal direction thereof. One or more oxygen supply balloons provided on the outer wall of the distal end portion and / or the intermediate portion of the main tube and communicating with the liquid supply lumen and the liquid recovery lumen, respectively, and at the base end of the main tube, A liquid supply tube and a liquid recovery tube connected to the liquid supply lumen and the liquid recovery lumen, respectively, when the oxygen supply balloon is formed of a gas-permeable and liquid-impermeable synthetic resin and the liquid is flowed. of the resistance of the liquid recovery side flow channel is larger than the resistance of the flow path of the liquid supply side, the main Chu
Close to the oxygen supply balloon on the outer wall of the
One piece made of permeable and liquid-impermeable synthetic resin
Or a plurality of carbon dioxide gas concentration measurement balloons.
Each measurement balloon separately in the main tube
CO2 concentration via the formed CO2 concentration lumen
A catheter for treating local anemia, which is connected to a degree measurement tube, is employed. Further, as a second invention, a catheter for treating local anemia according to claim 1, a liquid supply pump connected upstream of a liquid supply tube of the catheter for treatment of local anemia, and an upstream of the liquid supply pump And a liquid container connected downstream of the liquid recovery tube of the catheter for treating local anemia,
The treatment apparatus employs a treatment device in which the liquid container has connection means with oxygen gas supply means.
【0006】[0006]
【作用】上記の第1の発明の構成によれば、目的とする
たとえば腸管内に局所性貧血治療用カテーテルを挿入
し、これに液体を循環させる手段を接続して、酸素供給
バルーンに人工血液などの高い酸素溶解性を有する液体
を供給すると、人工血液は液体循環手段→液体供給チュ
ーブ→液体供給用ルーメン→酸素供給バルーン→液体回
収用ルーメン→液体回収チューブ→液体循環手段と循環
する一方、酸素供給バルーンは、液体回収側の流路の抵
抗が液体供給側の流路の抵抗よりも大きいので、循環す
る人工血液によって膨張させられ腸管の粘膜組織に密着
する。酸素供給バルーンの薄膜を挟んで粘膜組織と酸素
供給バルーン内の人工血液の間には酸素濃度勾配および
炭酸ガス濃度勾配が生じるので、酸素は濃度の高い人工
血液から酸素供給バルーンのガス透過性かつ液体不透過
性の薄膜を透過して粘膜組織に移行する。一方、炭酸ガ
スは濃度の高い粘膜組織から薄膜を透過して人工血液に
移行する。According to the structure of the first aspect of the present invention, a catheter for treating local anemia is inserted into a target, for example, the intestinal tract, and a means for circulating a liquid is connected to the catheter. When supplying a liquid having high oxygen solubility such as, the artificial blood circulates through the liquid circulation means → liquid supply tube → liquid supply lumen → oxygen supply balloon → liquid recovery lumen → liquid recovery tube → liquid circulation means, Since the resistance of the flow path on the liquid recovery side is greater than the resistance of the flow path on the liquid supply side, the oxygen supply balloon is inflated by the circulating artificial blood and adheres to the mucosal tissue of the intestinal tract. Since an oxygen concentration gradient and a carbon dioxide concentration gradient are generated between the mucosal tissue and the artificial blood in the oxygen supply balloon with the thin film of the oxygen supply balloon interposed therebetween, oxygen is supplied from the oxygenated balloon having a high concentration to the gas permeability of the oxygen supply balloon. It permeates through the liquid-impermeable membrane and into mucosal tissues. On the other hand, the carbon dioxide gas passes through the thin film from the highly concentrated mucosal tissue and transfers to artificial blood.
【0007】[0007]
【実施例】次に本発明の実施例について図面に基づいて
説明する。図1は第1の発明の説明図であり、図2は第
1の発明の他の実施例を示す説明図、図3は図2のA−
A線拡大端面図、図4は第2の発明の説明図である。図
1〜図2に示すように、本件第1の発明の局所性貧血治
療用カテーテルは、その長手方向に液体供給用ルーメン
11と液体回収用ルーメン12の形成されたメインチュ
ーブ1を有しており、このメインチューブ1の先端部お
よび/または中間部の外壁には1つまたは複数の酸素供
給バルーン2が設けられている。そして酸素供給バルー
ン2の内部には液体供給用ルーメン11および液体回収
用ルーメン12が開口しており、液体供給用ルーメン1
1および液体回収用ルーメン12にはメインチューブ1
の基端部でそれぞれ液体供給チューブ3および液体回収
チューブ4が接続されている。酸素供給バルーン2はガ
ス透過性かつ液体不透過性の合成樹脂で形成されてお
り、液体回収側の流路の抵抗が液体供給側の流路の抵抗
よりも大きくなっている。Next, an embodiment of the present invention will be described with reference to the drawings. FIG. 1 is an explanatory diagram of the first invention, FIG. 2 is an explanatory diagram showing another embodiment of the first invention, and FIG.
FIG. 4 is an explanatory view of the second invention in an enlarged end view along the line A. As shown in FIGS. 1 and 2, the local anemia treatment catheter according to the first aspect of the present invention has a main tube 1 in which a liquid supply lumen 11 and a liquid recovery lumen 12 are formed in a longitudinal direction thereof. One or a plurality of oxygen supply balloons 2 are provided on the outer wall of the main tube 1 at the distal end and / or the intermediate portion. A liquid supply lumen 11 and a liquid recovery lumen 12 are opened inside the oxygen supply balloon 2.
1 and the main tube 1
Are connected to a liquid supply tube 3 and a liquid recovery tube 4, respectively. The oxygen supply balloon 2 is made of a gas-permeable and liquid-impermeable synthetic resin, and the resistance of the flow path on the liquid recovery side is larger than the resistance of the flow path on the liquid supply side.
【0008】メインチューブ1は通常シリコーンゴムや
ポリウレタン、ポリ塩化ビニル、ポリアミドなどの合成
樹脂またはこれらの少なくとも1つを含んでなる共重合
体やブレンド体などで形成された柔軟なチューブであ
り、メインチューブ1の側壁にはその長手方向に縦走す
る液体供給用ルーメン11と液体回収用ルーメン12が
形成されている。そしてメインチューブ1の外壁にはそ
の先端部または中間部、または先端部から中間部にかけ
て1つまたは複数の酸素供給バルーン2が設けられてお
り、前記液体供給用ルーメン11と液体回収用ルーメン
12はこれらの酸素供給バルーン2の内部に開口してこ
れら全てと連通するとともに、メインチューブ1の基端
部でそれぞれ液体供給チューブ3および液体回収チュー
ブ4と接続されている。酸素供給バルーン2はガス透過
性かつ液体不透過性の合成樹脂、たとえばシリコーンゴ
ムやポリプロピレン、ポリテトラフルオロエチレン、ポ
リアルキルサルホン、ジターシャリーブチル・フマレー
ト、アラミド−シリコーン樹脂などで形成された膜から
なり、バルーンの数、長さ、太さを適当に調節すること
により、大腸や十二指腸、小腸等任意の消化管の部位に
対応させることができる。酸素供給バルーン2に供給さ
れる液体は酸素を高度に溶解または分散させた液体であ
り、酸素溶解性に優れ安全性の高い液体が望ましい。こ
のような液体としては、たとえばパーフルオロカーボン
(PFC)などの人工血液が好適に採用される。液体の
流れに対する流路の抵抗は、液体回収用ルーメン12と
液体回収チューブ4からなる液体回収側の方が、液体供
給用ルーメン11と液体供給チューブ3からなる液体供
給側よりも大きくなっている。液体回収側の流路の抵抗
を液体供給側の流路の抵抗より大きくする方法として
は、液体供給用ルーメン11の径を液体回収用ルーメン
12の径より大きくするなど液体供給側の流路の内径を
液体回収側の流路の内径よりも大きくする、液体回収側
流路に流量制御手段を取り付けて液体の流量を制限す
る、などがある。The main tube 1 is usually a flexible tube made of a synthetic resin such as silicone rubber, polyurethane, polyvinyl chloride, polyamide, or a copolymer or blend containing at least one of these. The side wall of the tube 1 is formed with a liquid supply lumen 11 and a liquid recovery lumen 12 that run longitudinally in the longitudinal direction. The outer wall of the main tube 1 is provided with one or a plurality of oxygen supply balloons 2 from the distal end or the intermediate portion, or from the distal end to the intermediate portion, and the liquid supply lumen 11 and the liquid recovery lumen 12 are provided. Opened inside the oxygen supply balloon 2 and communicated with all of them, the base end of the main tube 1 is connected to the liquid supply tube 3 and the liquid recovery tube 4 respectively. The oxygen supply balloon 2 is made of a film formed of a gas-permeable and liquid-impermeable synthetic resin such as silicone rubber, polypropylene, polytetrafluoroethylene, polyalkylsulfone, di-tert-butyl fumarate, and aramid-silicone resin. Thus, by appropriately adjusting the number, length, and thickness of the balloons, it is possible to correspond to any part of the digestive tract such as the large intestine, duodenum, and small intestine. The liquid supplied to the oxygen supply balloon 2 is a liquid in which oxygen is highly dissolved or dispersed, and a liquid having excellent oxygen solubility and high safety is desirable. As such a liquid, artificial blood such as perfluorocarbon (PFC) is preferably used. The resistance of the flow path to the flow of the liquid is higher on the liquid recovery side including the liquid recovery lumen 12 and the liquid recovery tube 4 than on the liquid supply side including the liquid supply lumen 11 and the liquid supply tube 3. . As a method for increasing the resistance of the flow path on the liquid recovery side to the resistance of the flow path on the liquid supply side, the diameter of the liquid supply lumen 11 may be made larger than the diameter of the liquid recovery lumen 12, for example. The inner diameter may be made larger than the inner diameter of the flow path on the liquid recovery side, or the flow rate control means may be attached to the flow path on the liquid recovery side to limit the flow rate of the liquid.
【0009】メインチューブ1には必要ならばさらに図
3に示すような、治療を行う前後あるいは途中に必要に
応じて組織の酸素欠乏の程度を調べるための炭酸ガス濃
度測定バルーン5と連通する炭酸ガス濃度測定用ルーメ
ン13や、治療部位の内容物等を排出するためのドレー
ン用ルーメン14を形成してもよい。炭酸ガス濃度測定
バルーン5は酸素供給バルーン2の形成材料と同様のガ
ス透過性かつ液体不透過性の合成樹脂で形成された膜か
らなり、メインチューブ1の外壁に酸素供給バルーン2
に近接して別途設けられる。炭酸ガス濃度測定用ルーメ
ン13はメインチューブ1の基端部で炭酸ガス濃度測定
チューブ6と接続されて、炭酸ガス濃度測定バルーン5
を炭酸ガス濃度測定用ルーメン13を介して炭酸ガス濃
度測定チューブ6と連通される。また、ドレーン用ルー
メン14は、一端がメインチューブ1の基端に開口され
て吸引手段(図示していない)との接続口(ドレーン
口)7と接続され、他端がメインチューブ1の先端側
(先端を含む)のドレーン用側孔15に開口されてい
る。ドレーン用側孔15は必要ならばメインチューブ1
の先端以外の適当な場所に追加して設けてもよい。尚、
炭酸ガス濃度測定バルーン5は通常酸素供給バルーン2
を挟むようにその両側に2個設けられるが、特に限定さ
れるものではなく、先端側だけに設けてもよく、酸素供
給バルーン2の間に設けてもよい。また、炭酸ガス濃度
測定用ルーメン13および炭酸ガス濃度測定チューブ6
は炭酸ガス濃度測定バルーン5と同数設けられる。図
中、16、17はそれぞれ、液体供給用ルーメン11を
酸素供給バルーン2に連通する側孔および液体回収用ル
ーメン12を酸素供給バルーン2に連通する側孔であ
る。If necessary, the main tube 1 is connected to a carbon dioxide concentration measuring balloon 5 for examining the degree of oxygen deficiency in the tissue before and after or during treatment as shown in FIG. A lumen 13 for measuring gas concentration and a drain lumen 14 for discharging the contents and the like of the treatment site may be formed. The carbon dioxide gas concentration measurement balloon 5 is made of a film formed of a gas-permeable and liquid-impermeable synthetic resin similar to the material for forming the oxygen supply balloon 2, and is provided on the outer wall of the main tube 1.
Is provided separately in the vicinity of The lumen 13 for measuring the concentration of carbon dioxide is connected to the tube 6 for measuring the concentration of carbon dioxide at the base end of the main tube 1 and the balloon 5 for measuring the concentration of carbon dioxide.
Is connected to a carbon dioxide concentration measuring tube 6 via a carbon dioxide concentration measuring lumen 13. The drain lumen 14 has one end opened at the base end of the main tube 1 and connected to a connection port (drain port) 7 with a suction means (not shown), and the other end connected to the distal end of the main tube 1. It is opened to the drain side hole 15 (including the tip). The drain side hole 15 is used for the main tube 1 if necessary.
May be additionally provided at an appropriate place other than the tip of the. still,
The carbon dioxide concentration measurement balloon 5 is a normal oxygen supply balloon 2
Are provided on both sides of the oxygen supply balloon 2, but are not particularly limited, and may be provided only on the distal end side or between the oxygen supply balloons 2. The lumen 13 for measuring carbon dioxide concentration and the tube 6 for measuring carbon dioxide concentration
Are provided in the same number as the carbon dioxide concentration measurement balloons 5. In the figure, reference numerals 16 and 17 denote side holes for connecting the liquid supply lumen 11 to the oxygen supply balloon 2 and side holes for connecting the liquid recovery lumen 12 to the oxygen supply balloon 2.
【0010】液体供給チューブ3、液体回収チューブ
4、炭酸ガス濃度測定チューブ6は、いずれもメインチ
ューブ1と同様の合成樹脂またはこれらの少なくとも1
つを含んでなる共重合体やブレンド体などで形成された
柔軟なチューブからなり、一端がそれぞれ液体供給用ル
ーメン11、液体回収用ルーメン12、炭酸ガス濃度測
定用ルーメン13に接続されており、他端にはそれぞれ
液体供給手段、液体回収手段、炭酸ガス濃度測定装置と
接続するためのコネクタ31、41、61が取り付けら
れている。尚、コネクタ31、41、61としては流路
切り換えのできる三方活栓等が好ましい。また、本発明
の局所性貧血治療用カテーテルに内視鏡を組み込むこと
もでき、その場合には、ドレーン用ルーメン14に内視
鏡を挿入し、治療部位の状態を観察することができる。
さらにまた、病態のより早期の確認を可能にするために
必要に応じてpH電極や酸素電極、炭酸ガス電極、温度
センサー等を組み込むことも可能である。The liquid supply tube 3, the liquid recovery tube 4, and the carbon dioxide concentration measuring tube 6 are all made of the same synthetic resin as the main tube 1 or at least one of them.
A flexible tube formed of a copolymer or a blend comprising one of them, one end of which is connected to a liquid supply lumen 11, a liquid recovery lumen 12, and a carbon dioxide concentration measurement lumen 13, respectively. At the other end, connectors 31, 41, and 61 for connecting to a liquid supply unit, a liquid recovery unit, and a carbon dioxide concentration measuring device are attached. Incidentally, as the connectors 31, 41, 61, a three-way stopcock or the like capable of switching the flow path is preferable. In addition, an endoscope can be incorporated into the catheter for treating local anemia of the present invention. In this case, the endoscope can be inserted into the drain lumen 14 to observe the state of the treatment site.
Furthermore, a pH electrode, an oxygen electrode, a carbon dioxide electrode, a temperature sensor, and the like can be incorporated as needed to enable earlier confirmation of a disease state.
【0011】次に、本件第2の発明の治療装置について
説明する。図4に示すように本発明の治療装置は、局所
性貧血治療用カテーテル10と、このカテーテル10に
高濃度に酸素を溶解した液体(以下酸素溶解液という)
たとえば人工血液を供給する手段としてのローラーポン
プ8、回収された酸素溶解液Sを貯留する液体収容容器
としての人工血液貯糟9、およびこれらを接続する導管
81、91、92からなり、人工血液貯糟9にはさらに
酸素ガス供給手段(図示していない)との接続手段とし
ての導管93が取り付けられている。酸素溶解液Sへの
酸素の溶解を促進するために、導管93の開口部は酸素
をバブリングさせることができるように好ましくは人工
血液貯糟9の底部に近接して配置されるが、人工血液貯
糟9内に別途酸素溶解液Sを攪拌する手段(図示してい
ない)を設けてもよい。Next, a treatment apparatus according to the second aspect of the present invention will be described. As shown in FIG. 4, the treatment apparatus of the present invention comprises a catheter 10 for treating local anemia and a liquid obtained by dissolving oxygen in the catheter 10 at a high concentration (hereinafter referred to as an oxygen solution).
For example, it is composed of a roller pump 8 as a means for supplying artificial blood, an artificial blood reservoir 9 as a liquid container for storing the recovered oxygen solution S, and conduits 81, 91, and 92 connecting these. The reservoir 9 is further provided with a conduit 93 as connection means for connecting to oxygen gas supply means (not shown). In order to facilitate the dissolution of oxygen in the oxygen solution S, the opening of the conduit 93 is preferably arranged close to the bottom of the artificial blood reservoir 9 so that oxygen can be bubbled. A means (not shown) for stirring the oxygen solution S may be separately provided in the reservoir 9.
【0012】次に、本発明の治療装置の使用状況につい
て説明する。先ず局所性貧血治療用カテーテル10の液
体供給チューブ3および液体回収チューブ4のコネクタ
31、41を利用してシリンジ等を用いてカテーテル1
0内の空気を出来るだけ抜き、腸管内に内容物がある場
合は、適時ドレーン口7より洗浄液を注入してドレーン
を行う。次いで、目的とする腸管内にカテーテル10を
挿入する。カテーテル10の挿入には、開腹時直接腸管
壁から挿入する方法、経鼻的、経口的に挿入する方法、
肛門から結腸内に挿入する方法、さらには腹腔鏡を用い
て経皮的に挿入する方法等、患者の状況等に応じて適宜
の方法が採用される。ローラーポンプ8を駆動させる
と、人工血液貯糟9内の酸素溶解液Sは導管92内に吸
い上げられ、導管92から導管81へと流れて局所性貧
血治療用カテーテル10の液体供給チューブ3に流入す
る。そして、液体供給用ルーメン11を通って酸素供給
バルーン2内に流入し、次いで液体回収用ルーメン12
から液体回収チューブ4、導管91と流れて人工血液貯
糟9内に回収される。このように酸素溶解液Sが人工血
液貯糟9→ローラーポンプ8→局所性貧血治療用カテー
テル10→人工血液貯糟9と循環する間に、酸素供給バ
ルーン2内の酸素溶解液Sは、酸素供給バルーン2の膜
21を介して治療部位の粘膜(図示していない)に酸素
を供給する。一方、人工血液貯糟9には酸素供給手段か
ら導管93を通って酸素ガスが供給され、この酸素が回
収された酸素溶解液Sに溶解させられ、酸素溶解液Sの
再利用が行われる。尚、必要に応じて治療の前後または
途中で炭酸ガス濃度測定バルーン5内に生理食塩水を注
入、排出し、組織の酸素欠乏の状態を調査してもよい。
また、酸素溶解液Sの循環速度は約4.0ml/sec程度が
適当であるが、状況に応じて変化させてもよい。Next, the usage of the treatment apparatus of the present invention will be described. First, the catheter 1 is connected to the catheter 1 using a syringe or the like by using the connectors 31 and 41 of the liquid supply tube 3 and the liquid recovery tube 4 of the catheter 10 for treating local anemia.
As much air as possible is drained from the inside of the intestine, and if there is a content in the intestinal tract, the washing liquid is injected from the drain port 7 at an appropriate time to drain. Next, the catheter 10 is inserted into a target intestinal tract. The method of inserting the catheter 10 directly from the intestinal wall at the time of laparotomy, transnasally, orally,
An appropriate method is adopted according to the situation of the patient, such as a method of inserting into the colon from the anus and a method of percutaneous insertion using a laparoscope. When the roller pump 8 is driven, the oxygen solution S in the artificial blood reservoir 9 is sucked into the conduit 92, flows from the conduit 92 to the conduit 81, and flows into the liquid supply tube 3 of the local anemia treatment catheter 10. I do. Then, the liquid flows into the oxygen supply balloon 2 through the liquid supply lumen 11, and then flows into the liquid recovery lumen 12.
Then, it flows through the liquid collection tube 4 and the conduit 91 to be collected in the artificial blood reservoir 9. As described above, while the oxygen solution S circulates through the artificial blood reservoir 9 → the roller pump 8 → the local anemia treatment catheter 10 → the artificial blood reservoir 9, the oxygen solution S in the oxygen supply balloon 2 Oxygen is supplied to the mucous membrane (not shown) at the treatment site via the membrane 21 of the supply balloon 2. On the other hand, oxygen gas is supplied from the oxygen supply means to the artificial blood reservoir 9 through the conduit 93, and this oxygen is dissolved in the recovered oxygen solution S, and the oxygen solution S is reused. In addition, if necessary, physiological saline may be injected into and discharged from the carbon dioxide concentration measurement balloon 5 before or after or during the treatment, and the state of oxygen deficiency in the tissue may be investigated.
The circulation rate of the oxygen solution S is suitably about 4.0 ml / sec, but may be changed according to the situation.
【0013】〔実験例1〕雑種雄成犬を全身麻酔下で開
腹し、その小腸Dの管壁の一部を小切開し、図5に示す
ような局所性貧血治療用カテーテル10を挿入した後、
挿入した小腸Dに繋がる上腸間膜動脈を結紮し、酸素供
給バルーン2内に酸素分圧約600mmHgまで酸素を溶解
させた人工血液(PFC乳剤)を充填し、約4.0ml/s
ecの速度で循環させながら、経時的に小腸粘膜組織の炭
酸ガス濃度を測定してpHを算出するとともに、治療開
始2時間後に粘膜の一部を採取して、粘膜表面の状態を
走査型電子顕微鏡および透過型電子顕微鏡で観察した。
その結果を表1に示す。尚、カテーテル10のメインチ
ューブ1の直径は16Fr(約5.3mm)であり、酸素供
給バルーン2および炭酸ガス濃度測定バルーン5、コン
トロール部分の炭酸ガス濃度を測定するためのコントロ
ールバルーンCのサイズは直径15mm×長さ50mmであ
り、どちらもシリコーンゴムで形成されている。表1か
ら、酸素供給バルーン2に接触した粘膜の部分のpHの
低下が進んでおらず、局所性貧血治療用カテーテルを用
いた治療により、組織のアシドーシス、すなわち酸素不
足状態に陥るのを防いでいるのが分かる。また、走査型
電子顕微鏡および透過型電子顕微鏡による小腸粘膜の観
察でも、治療効果が認められるのが分かる。[Experimental Example 1] A male adult dog was laparotomized under general anesthesia, a small incision was made in a part of the wall of the small intestine D, and a local anemia treatment catheter 10 as shown in FIG. 5 was inserted. rear,
The superior mesenteric artery connected to the inserted small intestine D was ligated, and the oxygen supply balloon 2 was filled with artificial blood (PFC emulsion) in which oxygen was dissolved to an oxygen partial pressure of about 600 mmHg, and about 4.0 ml / s.
While circulating at the speed of ec, the concentration of carbon dioxide in the small intestinal mucosal tissue is measured over time to calculate the pH, and two hours after the start of the treatment, a part of the mucous membrane is collected, and the state of the mucosal surface is scanned. Observation was performed with a microscope and a transmission electron microscope.
Table 1 shows the results. The diameter of the main tube 1 of the catheter 10 is 16 Fr (about 5.3 mm), and the sizes of the oxygen supply balloon 2, the carbon dioxide concentration measurement balloon 5, and the control balloon C for measuring the carbon dioxide concentration of the control portion are as follows. It is 15 mm in diameter × 50 mm in length, and both are formed of silicone rubber. From Table 1, it can be seen that the pH of the mucous membrane in contact with the oxygen supply balloon 2 has not been reduced, and the treatment with a local anemia treatment catheter prevents acidosis of the tissue, that is, an oxygen-deficient state. You can see that Observation of the small intestinal mucosa with a scanning electron microscope and a transmission electron microscope also shows that a therapeutic effect is observed.
【0014】[0014]
【表1】 [Table 1]
【0015】[0015]
【発明の効果】以上説明してきたことから明らかなよう
に、本発明の局所性貧血治療用カテーテルを採用するこ
とにより、次のような効果を奏することができる。 酸素供給バルーンを腸管の粘膜に接触させて膜を介し
て酸素を供給する方式なので、腸管の閉塞や患者の体位
による影響がなく、均一に酸素を供給することができ
る。 各バルーンの大きさ、数を調節することによって、様
々な部位に対応させることができる。 バルーンに充填する酸素溶解液は殆ど汚染されないた
め、使用後回収することによって再利用が可能である。 粘膜組織の炭酸ガス濃度測定機能を持つバルーンや色
々なセンサーを組み合わせることにより、病態の予知や
予防を同時に行うことができる。 ドレーン用ルーメンを設けることにより、腸管内の洗
浄が可能であり、腸管汚物による影響を回避することが
できる。As apparent from the above description, the following effects can be obtained by employing the catheter for treating local anemia of the present invention. Since oxygen is supplied through the membrane by bringing the oxygen supply balloon into contact with the mucous membrane of the intestinal tract, oxygen can be supplied uniformly without obstruction of the intestinal tract or the influence of the patient's body position. By adjusting the size and number of each balloon, it is possible to correspond to various parts. Since the oxygen solution filled in the balloon is hardly contaminated, it can be reused by collecting it after use. By combining a balloon having a function of measuring the concentration of carbon dioxide in mucosal tissue and various sensors, it is possible to simultaneously predict and prevent a disease state. By providing the drain lumen, the inside of the intestinal tract can be washed, and the influence of intestinal contaminants can be avoided.
【図1】第1の発明の局所性貧血治療用カテーテルの説
明図である。FIG. 1 is an explanatory view of a catheter for treating local anemia of the first invention.
【図2】第1の発明の他の実施例を示す説明図である。FIG. 2 is an explanatory view showing another embodiment of the first invention.
【図3】図2のA−A線拡大端面図である。FIG. 3 is an enlarged end view taken along line AA of FIG. 2;
【図4】第2の発明の治療装置の説明図である。FIG. 4 is an explanatory view of a treatment apparatus of the second invention.
【図5】実験例1で小腸に局所性貧血治療用カテーテル
を挿入した状態を説明するための図である。FIG. 5 is a view for explaining a state in which a catheter for treating local anemia is inserted into the small intestine in Experimental Example 1.
1 メインチューブ 11 液体供給用ルーメン 12 液体回収用ルーメン 13 炭酸ガス濃度測定用ルーメン 14 ドレーン用ルーメン 2 酸素供給バルーン 3 液体供給チューブ 4 液体回収チューブ 5 炭酸ガス濃度測定バルーン 6 炭酸ガス濃度測定チューブ 7 ドレーン口 8 ローラーポンプ 9 人工血液貯糟 10 局所性貧血治療用カテーテル S 酸素溶解液 D 小腸 Reference Signs List 1 main tube 11 lumen for liquid supply 12 lumen for liquid recovery 13 lumen for carbon dioxide concentration measurement 14 lumen for drain 2 oxygen supply balloon 3 liquid supply tube 4 liquid recovery tube 5 carbon dioxide concentration measurement balloon 6 carbon dioxide concentration measurement tube 7 drain Mouth 8 Roller pump 9 Artificial blood reservoir 10 Local anemia treatment catheter S Oxygen solution D Small intestine
───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.7,DB名) A61M 1/00 A61M 25/00 A61M 31/00 A61M 37/00 ──────────────────────────────────────────────────続 き Continued on the front page (58) Fields investigated (Int. Cl. 7 , DB name) A61M 1/00 A61M 25/00 A61M 31/00 A61M 37/00
Claims (5)
び液体回収用ルーメンが形成されてなるメインチューブ
と、該メインチューブの先端部および/または中間部の
外壁に設けられ、前記液体供給用ルーメンおよび液体回
収用ルーメンとそれぞれ連通する1つまたは複数の酸素
供給バルーンと、前記メインチューブの基端部で前記液
体供給用ルーメンおよび液体回収用ルーメンにそれぞれ
接続された液体供給チューブおよび液体回収チューブと
からなり、酸素供給バルーンをガス透過性かつ液体不透
過性の合成樹脂で形成するとともに、液体を流したとき
の液体回収側の流路の抵抗を液体供給側の流路の抵抗よ
りも大きくし、前記メインチューブの外壁に酸素供給用
バルーンに近接して、さらにガス透過性かつ液体不透過
性の合成樹脂で製せられた1つまたは複数の炭酸ガス濃
度測定バルーンを設け、該炭酸ガス濃度測定バルーンを
それぞれメインチューブに別途形成した炭酸ガス濃度測
定用ルーメンを介して炭酸ガス濃度測定チューブと連通
接続したことを特徴とする局所性貧血治療用カテーテ
ル。1. A main tube in which a liquid supply lumen and a liquid recovery lumen are formed in a longitudinal direction thereof, and a main tube provided on an outer wall at a distal end and / or an intermediate portion of the main tube. One or more oxygen supply balloons respectively communicating with the liquid collection lumen, and a liquid supply tube and a liquid collection tube respectively connected to the liquid supply lumen and the liquid collection lumen at the base end of the main tube. The oxygen supply balloon is formed of a gas-permeable and liquid-impermeable synthetic resin, and the resistance of the flow path on the liquid recovery side when flowing the liquid is made larger than the resistance of the flow path on the liquid supply side , For supplying oxygen to the outer wall of the main tube
Closer to the balloon, more gas permeable and liquid impermeable
One or more carbon dioxide enriched
A balloon for measuring the carbon dioxide concentration.
Carbon dioxide concentration measurement separately formed on each main tube
Communicates with carbon dioxide concentration measurement tube via regular lumen
A catheter for treating local anemia, wherein the catheter is connected.
供給バルーンおよび炭酸ガス濃度測定バルーンの外側に
開口するドレーン用ルーメンを別途形成し、該ドレーン
用ルーメンをドレーンチューブと連通接続した請求項1
に記載の局所性貧血治療用カテーテル。2. Separately forming a drain lumen which opens outwardly in the longitudinal direction to further oxygenation balloon and measuring carbon dioxide concentration balloon of the main tube, according to claim 1 in which the drain lumen connects drain tube communicating with
4. The catheter for treating local anemia according to claim 1.
がシリコーンゴム、ポリプロピレン、ポリテトラフルオ
ロエチレン、ポリアルキルサルホン、ジターシャリーブ
チル・フマレート、アラミド−シリコーン樹脂の群から
選ばれる1つ、または2つ以上の組合せからなる請求項
1または2に記載の局所性貧血治療用カテーテル。3. A gas-permeable and liquid-impermeable synthetic resin selected from the group consisting of silicone rubber, polypropylene, polytetrafluoroethylene, polyalkylsulfone, di-tert-butyl fumarate, and aramid-silicone resin. Or claims consisting of a combination of two or more
3. The catheter for treating local anemia according to 1 or 2 .
ーメンの径よりも大きく形成した請求項1〜3のいずれ
かに記載の局所性貧血治療用カテーテル。4. The catheter for treating local anemia according to claim 1 , wherein the diameter of the liquid supply lumen is larger than the diameter of the liquid recovery lumen.
ーテルと、該局所性貧血治療用カテーテルの液体供給チ
ューブの上流に接続された液体供給ポンプ、および該液
体供給ポンプの上流と局所性貧血治療用カテーテルの液
体回収チューブの下流に接続された液体収容容器からな
り、該液体収容容器が酸素ガス供給手段との接続手段を
有している治療装置。5. The local anemia treatment catheter according to claim 1, a liquid supply pump connected upstream of a liquid supply tube of the local anemia treatment catheter, and an upstream and locality of the liquid supply pump. A treatment apparatus comprising a liquid storage container connected downstream of a liquid recovery tube of an anemia treatment catheter, wherein the liquid storage container has a connection means with an oxygen gas supply means.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP05027321A JP3141601B2 (en) | 1993-01-22 | 1993-01-22 | CATHETER FOR TREATMENT OF LOCAL ANEMIA AND TREATMENT DEVICE USING THE SAME |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP05027321A JP3141601B2 (en) | 1993-01-22 | 1993-01-22 | CATHETER FOR TREATMENT OF LOCAL ANEMIA AND TREATMENT DEVICE USING THE SAME |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH06218048A JPH06218048A (en) | 1994-08-09 |
JP3141601B2 true JP3141601B2 (en) | 2001-03-05 |
Family
ID=12217815
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP05027321A Expired - Fee Related JP3141601B2 (en) | 1993-01-22 | 1993-01-22 | CATHETER FOR TREATMENT OF LOCAL ANEMIA AND TREATMENT DEVICE USING THE SAME |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3141601B2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1357395A (en) * | 2000-12-08 | 2002-07-10 | 杭州泰士生物科技有限公司 | Waveform for treating functional gastrointestinal disease and cure instrument to output the waveform |
US7862601B2 (en) * | 2005-05-23 | 2011-01-04 | Incept Llc | Apparatus and methods for delivering a stent into an ostium |
JP2023166037A (en) * | 2020-09-30 | 2023-11-20 | テルモ株式会社 | Catheter and cerebral infarction treatment device |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4631053A (en) | 1984-03-19 | 1986-12-23 | Taheri Syde A | Oxygenator |
-
1993
- 1993-01-22 JP JP05027321A patent/JP3141601B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4631053A (en) | 1984-03-19 | 1986-12-23 | Taheri Syde A | Oxygenator |
Also Published As
Publication number | Publication date |
---|---|
JPH06218048A (en) | 1994-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5746717A (en) | Balloon catheter and device for perfusion with the balloon catheter | |
US4671287A (en) | Apparatus and method for sustaining vitality of organs of the gastrointestinal tract | |
EP0168439B1 (en) | Intraluminal membrane oxygenator | |
US8425455B2 (en) | Bronchial catheter and method of use | |
Huntington et al. | Techniques for measuring blood flow in splanchnic tissues of cattle | |
JP4335523B2 (en) | Peritoneal dialysis catheter | |
US4637814A (en) | Method and apparatus for intestinal irrigation | |
EP0787021B1 (en) | Systems for promoting tissue growth | |
US3788328A (en) | Cardiovascular catheter | |
US7785246B2 (en) | Left and right side heart support | |
US6086553A (en) | Arteriovenous shunt | |
JPH09505505A (en) | Bladder oxygen measurement | |
JP2003511111A (en) | Combined examination catheter for left ventricle and right and left coronary arteries | |
JP2004529666A (en) | Prosthesis for peritoneal dialysis and method of performing peritoneal dialysis | |
JP3141601B2 (en) | CATHETER FOR TREATMENT OF LOCAL ANEMIA AND TREATMENT DEVICE USING THE SAME | |
JP3252274B2 (en) | Rectal catheter | |
CN109364320B (en) | Full-colon perfusion indwelling catheter and fixing method thereof | |
Salim | Percutaneous decompression and irrigation for large bowel obstruction: New approach | |
Caponas et al. | Difficulty in use and device failure with the intubating laryngeal mask airway® | |
Togal et al. | Anaesthesia for Caesarean section in the presence of aortic coarctation | |
JP2024117600A (en) | Blood carbon dioxide removal system using intraperitoneal perfusion | |
WO2024049475A1 (en) | Automated patient support | |
RU2446756C1 (en) | Method of treating purulent-necrotic pancreonecrosis | |
Blodgett et al. | Intestinal Suction | |
Kayacan et al. | Hysteroscopic syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |